SCHEMBL5456286

SCHEMBL5456286

O=C(NO)c1ccc(-c2ccc(CNCCCCO)cc2)o1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.45
LMNA P02545 4/20 0.45
ALDH1A1 P00352 3/20 0.45
HPGD P15428 2/20 0.45
HDAC3 O15379 6/20 0.42
HDAC1 Q13547 6/20 0.42
HDAC2 Q92769 6/20 0.42
HDAC8 Q9BY41 6/20 0.42
NCOR2 Q9Y618 2/20 0.42
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HRH4 Q9H3N8 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
HDAC4 P56524 2/20 0.40
HDAC7 Q8WUI4 2/20 0.40
HDAC10 Q969S8 2/20 0.40
HDAC11 Q96DB2 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5450927 0.86 SUCNR1 (0.45) KDM4ELMNAALDH1A1HPGDHDAC1
SCHEMBL8289895 0.85 KDM4E (0.52) KDM4ELMNAALDH1A1HPGDHDAC3
SCHEMBL5450454 0.85 SUCNR1 (0.47) KDM4ELMNAALDH1A1HPGDHDAC3
SCHEMBL5449580 0.84 HTT (0.45) KDM4ELMNAALDH1A1HPGDHDAC8
SCHEMBL5453734 0.81 ALDH1A1 (0.53) KDM4ELMNAALDH1A1HPGDHDAC1
SCHEMBL5448334 0.81 KDM4E (0.58) KDM4ELMNAALDH1A1HPGDHDAC8
SCHEMBL5442839 0.81 HDAC1 (0.46) KDM4ELMNAALDH1A1HPGDHDAC1
SCHEMBL4423968 0.81 KDM4E (0.60) KDM4ELMNAALDH1A1HPGDHDAC1
SCHEMBL5446773 0.80 KDM4E (0.48) KDM4ELMNAALDH1A1HPGDHDAC1
SCHEMBL5452564 0.79 ALDH1A1 (0.66) LMNAALDH1A1MAPTMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications A*BIO PTE LTD. (SG) 2007-07-19 US disclosed
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications A*BIO PTE LTD. (SG) 2007-07-19 US disclosed
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications A*BIO PTE LTD. (SG) 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167499-A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications HDAC1, HDAC11, HDAC2 KDM4E 454/4885LMNA 672/4885ALDH1A1 447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.